USPH Cash from 2010 to 2024

USPH Stock  USD 92.10  2.51  2.65%   
US Physicalrapy's Cash is increasing with slightly volatile movements from year to year. Cash is estimated to finish at about 160.5 M this year. Cash is the total amount of money in the form of currency that US Physicalrapy has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
1991-12-31
Previous Quarter
112.9 M
Current Value
117 M
Quarterly Volatility
28.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.8 M, Total Revenue of 635 M or Gross Profit of 117.6 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0194 or PTB Ratio of 4.71. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
  
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Latest US Physicalrapy's Cash Growth Pattern

Below is the plot of the Cash of US Physicalrapy over the last few years. Cash refers to the most liquid asset of US Physicalrapy, which is listed under current asset account on US Physicalrapy balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from US Physicalrapy customers. The amounts must be unrestricted with restricted cash listed in a different US Physicalrapy account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. US Physicalrapy's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in US Physicalrapy's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

USPH Cash Regression Statistics

Arithmetic Mean37,451,150
Geometric Mean21,724,862
Coefficient Of Variation131.21
Mean Deviation31,785,193
Median21,933,000
Standard Deviation49,139,652
Sample Variance2414.7T
Range158.6M
R-Value0.72
Mean Square Error1265.8T
R-Squared0.51
Significance0
Slope7,871,817
Total Sum of Squares33805.9T

USPH Cash History

2024160.5 M
2023152.8 M
202231.6 M
202128.6 M
202032.9 M
201923.5 M
201823.4 M

Other Fundumenentals of US Physicalrapy

US Physicalrapy Cash component correlations

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's Cash, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cash152.8 M160.5 M
Cash And Short Term Investments152.8 M160.5 M
Change In Cash121.2 M127.3 M
Free Cash Flow73.5 M77.2 M
Other Cashflows From Financing Activities-16.1 M-15.3 M
Other Non Cash Items42.2 M44.3 M
Total Cash From Operating Activities82.8 M86.9 M
Total Cash From Financing Activities84.3 M88.5 M
End Period Cash Flow152.8 M160.5 M
Begin Period Cash Flow31.6 M33.2 M
Other Cashflows From Investing Activities-103.3 M-98.1 M
Total Cashflows From Investing Activities-73.1 M-69.5 M
Cash And Cash Equivalents Changes-5 M-4.8 M
Cash Flows Other Operating-728 K-691.6 K
Free Cash Flow Yield 0.06  0.04 
Operating Cash Flow Per Share 5.84  6.13 
Free Cash Flow Per Share 5.18  5.44 
Cash Per Share 10.96  11.51 
Capex To Operating Cash Flow 0.11  0.10 
EV To Operating Cash Flow 17.24  18.10 
EV To Free Cash Flow 19.41  10.42 
Price To Operating Cash Flows Ratio 15.96  16.76 
Price To Free Cash Flows Ratio 17.98  9.73 
Cash Ratio 1.50  1.73 
Cash Conversion Cycle 38.48  56.82 
Operating Cash Flow Sales Ratio 0.14  0.14 
Free Cash Flow Operating Cash Flow Ratio 0.89  0.96 
Cash Flow Coverage Ratios 0.46  0.43 
Price Cash Flow Ratio 15.96  16.76 
Cash Flow To Debt Ratio 0.46  0.43 

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.75
Earnings Share
0.88
Revenue Per Share
42.489
Quarterly Revenue Growth
0.12
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.